Abbott Laboratories
ABT· NYSE
ABTAbbott Laboratories
Source filing unavailable
| Metric | Q4 2009 | Q4 2008 |
|---|---|---|
| Revenue | $8.79B | $7.95B |
| Net Income | $1.54B | $1.54B |
| EPS Diluted | $0.98 | $0.98 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
